Skip to main content
. 2014 Mar 15;7(4):1616–1624.

Table 4.

The relationship between clinical characteristics and 1-, 3- or 5-year survival rates in 80 uterine sarcoma patients in Changhai Hospital

Prognostic Factors Number P value 1-year 3-year 5-year

n % n % n %
Age Range (years) <0.001
    40 and below 2 2 100 2 100 2 100
    41-50 14 13 92.9 11 78.6 10 71.4
    51-60 39 34 87.2 27 69.2 17 43.6
    61-70 21 14 66.7 10 47.6 3 14.3
    71-80 3 2 66.7 0 0 0 0
    81 and above 1 0 0 0 0 0 0
Blood Type 0.009
    A 32 26 81.3 18 56.3 9 28.1
    B 28 21 75.0 15 53.6 7 25.0
    O 14 13 92.9 12 85.7 12 85.7
    AB 6 5 83.3 5 83.3 4 66.7
Menopausal Status 0.001
    Pre-menopausal 24 20 83.3 17 70.8 17 70.8
    Post-menopausal 56 45 80.4 33 58.9 15 26.8
Clinical Stages 0.0036
    I 34 34 100.0 33 97.1 25 73.5
    II 6 6 100.0 4 66.7 3 50.0
    III 22 17 77.3 9 40.9 4 18.2
    IV 18 8 44.4 4 22.2 0 0
Pathologic Types <0.001
    ESS low malignancy 24 24 100.0 24 100.0 20 83.3
high malignancy 14 11 78.6 8 57.1 5 35.7
Total 38 35 92.1 32 84.2 25 65.8
    LMS 22 18 81.8 11 50.0 5 22.7
    CS 18 12 66.7 7 38.9 2 11.1
    undifferentiated 2 0 0 0 0 0 0
Surgery Scope 0.256
    AH 79 65 82.3 50 63.3 31 39.2
    AH+BSO 58 48 82.8 36 62.1 19 32.8
    AH+BSO+PLND 16 13 81.3 11 68.8 5 31.3
    AH+BSO+OE 30 25 83.3 20 66.7 8 26.7
Total 80 65 81.3 50 62.5 32 40.0